🔗 Permalink

Inventor profile of:

Holger Petersen

City:

Eimeldingen

Country:

Germany

Published Applications:

Last publication date:

2025-06-26

Top Assignees for applications by Holger Petersen

The entities that hold a legal rights for patent applications filed by inventor Petersen Holger:

NOVARTIS AG 7 Basel, Switzerland
VERNALIS (R&D) LTD. 1 Winnersh, Berkshire, United Kingdom
Nivartus AG 1 Basel, Switzerland

Recent patent applications by Petersen Holger

Holger Petersen from Eimeldingen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-26

US20250205147A1

Human necessities

Octreotide Depot Formulation with Constantly High Exposure Levels

#2 | 2025-03-13

US20250082718A1

Human necessities

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS

#3 | 2024-03-14

US20240082148A1

Human necessities

Octreotide Depot Formulation with Constantly High Exposure Levels

#4 | 2022-09-22

US20220296675A1

Human necessities

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS

#5 | 2021-06-03

US20210161806A1

Human necessities

Octreotide Depot Formulation with Constantly High Exposure Levels

#6 | 2020-07-02

US20200206306A1

Human necessities

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS

#7 | 2018-05-24

US20180140662A1

Human necessities

Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-co-glycolide Polymers

#8 | 2016-05-05

US20160120935A1

Human necessities

Sustanined Release Formulation Comprising Octreotide and Two or More Polyactide-co-glycolide Polymers

#9 | 2015-02-05

US20150037420A1

Human necessities

Sustained Release Formulation Comprising Octreotide and Two or More Polyactide-co-glycolide Polymers

#10 | 2012-09-06

US20120226224A1

Human necessities

Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers

#11 | 2012-07-05

US20120172592A1

Chemistry; metallurgy

Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms

#12 | 2011-01-06

US20110003002A1

Human necessities

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS

#13 | 2010-10-21

US20100266704A1

Human necessities

OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS

#14 | 2010-04-15

US20100093732A1

Chemistry; metallurgy

Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms

#15 | 2010-03-04

US20100056481A1

Chemistry; metallurgy

CRYSTALLINE FORMS OF ZOLEDRONIC ACID

#16 | 2010-02-25

US20100047306A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING BISPHOSPONATES

#17 | 2009-01-01

US20090004283A1

Human necessities

Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-Co-Glycolide Polymers

InventorID:

1058292 ⎘